Clinical Trial Update: Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amyloid plaque deposition in chemotherapy-induced cognitive impairment among breast cancer patients was terminated, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Utah | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-11-20